股票/基金 实时行情 股吧

简称:翰宇药业 代码:300199


会计年度:2015-06-30收入分布
项目名称主营业务收入主营业务成本主营业务毛利毛利率
醋酸去氨加压素注射液14,117,206.787,961,585.036,155,621.7543.60
固体类1,261,188.031,835,998.34-574,810.31-45.58
国外56,856,737.719,397,325.9947,459,411.7283.47
华北区87,875,441.5011,892,448.1675,982,993.3486.47
华东区31,525,183.817,044,808.3324,480,375.4877.65
华南区21,608,772.105,731,313.1915,877,458.9173.48
华西区19,370,220.6413,195,344.956,174,875.6931.88
华中区47,853,224.6210,303,813.3637,549,411.2678.47
客户肽41,884,700.764,960,280.1436,924,420.6288.16
其他制剂16,158,551.7211,318,247.404,840,304.3229.96
其中:注射用胸腺五肽51,602,320.296,247,627.0445,354,693.2587.89
器械类14,835,213.712,379,356.6812,455,857.0383.96
药品组合包装产品9,479,102.643,172,251.936,306,850.7166.53
医药制造业265,089,580.3857,565,053.98207,524,526.4078.28
原料药15,794,642.834,767,500.9711,027,141.8669.82
制剂181,834,732.4140,449,665.92141,385,066.4977.75
注射用生长抑素49,340,985.2013,981,746.2235,359,238.9871.66
注射用特利加压素50,615,668.42940,460.2349,675,208.1998.14

会计年度:2014-12-31 
项目名称主营业务收入主营业务成本主营业务毛利毛利率
医药制造业417,185,948.6371,965,663.93345,220,284.7082.75

会计年度:2014-06-30 
项目名称主营业务收入主营业务成本主营业务毛利毛利率
醋酸去氨加压素注射液13,410,043.395,119,617.748,290,425.6561.82
国外3,282,477.991,407,357.461,875,120.5357.13
华北区29,980,774.363,690,525.9726,290,248.3987.69
华东区35,060,139.733,017,421.5732,042,718.1691.39
华南区24,429,795.644,210,804.7620,218,990.8882.76
华西区44,740,424.728,180,600.1536,559,824.5781.72
华中区18,648,987.974,779,387.5113,869,600.4674.37
客户肽2,569,101.941,358,189.491,210,912.4547.13
其他制剂1,952,862.281,192,021.16760,841.1238.96
其中:注射用胸腺五肽66,433,507.8911,261,224.9455,172,282.9583.05
医药制造业156,142,600.4125,286,097.42130,856,502.9983.81
制剂153,573,498.4723,927,907.93129,645,590.5484.42
注射用生长抑素19,572,794.095,824,553.6613,748,240.4370.24
注射用特利加压素52,204,290.82530,490.4351,673,800.3998.98

会计年度:2013-12-31 
项目名称主营业务收入主营业务成本主营业务毛利毛利率
医药制造业299,919,474.9246,210,056.39253,709,418.5384.59

会计年度:2013-06-30 
项目名称主营业务收入主营业务成本主营业务毛利毛利率
医药制造业116,542,366.0022,040,502.0094,501,864.0081.09

    3/4 转到